Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1267648.RANou_yeFrH_pq3FH0YPbWOoX0l4FkNMLH2O9I9nevZUA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1267648.RANou_yeFrH_pq3FH0YPbWOoX0l4FkNMLH2O9I9nevZUA130_assertion type Assertion NP1267648.RANou_yeFrH_pq3FH0YPbWOoX0l4FkNMLH2O9I9nevZUA130_head.
- NP1267648.RANou_yeFrH_pq3FH0YPbWOoX0l4FkNMLH2O9I9nevZUA130_assertion description "[Even with the most conservative Bonferroni adjustment, two 2-SNP-haplotypes in SLC41A2 and MRS2 region were significantly associated with T2D risk (rs12582312-rs10861279: P = 0.0006; rs1056285-rs7738943: P = 0.002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267648.RANou_yeFrH_pq3FH0YPbWOoX0l4FkNMLH2O9I9nevZUA130_provenance.
- NP1267648.RANou_yeFrH_pq3FH0YPbWOoX0l4FkNMLH2O9I9nevZUA130_assertion evidence source_evidence_literature NP1267648.RANou_yeFrH_pq3FH0YPbWOoX0l4FkNMLH2O9I9nevZUA130_provenance.
- NP1267648.RANou_yeFrH_pq3FH0YPbWOoX0l4FkNMLH2O9I9nevZUA130_assertion SIO_000772 25733456 NP1267648.RANou_yeFrH_pq3FH0YPbWOoX0l4FkNMLH2O9I9nevZUA130_provenance.
- NP1267648.RANou_yeFrH_pq3FH0YPbWOoX0l4FkNMLH2O9I9nevZUA130_assertion wasDerivedFrom befree-2016 NP1267648.RANou_yeFrH_pq3FH0YPbWOoX0l4FkNMLH2O9I9nevZUA130_provenance.
- NP1267648.RANou_yeFrH_pq3FH0YPbWOoX0l4FkNMLH2O9I9nevZUA130_assertion wasGeneratedBy ECO_0000203 NP1267648.RANou_yeFrH_pq3FH0YPbWOoX0l4FkNMLH2O9I9nevZUA130_provenance.